Skip to content

NBI to Detect Post-RT Mucosal Residual NPC

Using Narrow-band Imaging (NBI) Technique to Detect Post-radiotherapy Mucosal Residual Nasopharyngeal Carcinoma (NPC)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02584790
Enrollment
55
Registered
2015-10-23
Start date
2015-11-30
Completion date
2017-04-30
Last updated
2017-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nasopharyngeal Carcinoma

Keywords

Nasopharyngeal carcinoma, Narrow band imaging

Brief summary

NBI has been proven to be a useful tool to detect early NPC, but they were few studies concerning the detection of post-radiotherapy mucosal residual NPC using NBI system

Detailed description

Background NPC has a uniquely high prevalence in Southern China. According to the Hong Kong Cancer Registry in 2012, NPC was the sixth commonest cancer in men and thirteenth in women. It accounted for 2.9% of all new cancer cases. In 2012, there were 819 new cases of NPC. NPC is highly radiosensitive. Radiotherapy and chemotherapy are the mainstay of treatment. Despite the chemo-irradiation, disease control failure still occurred in NPC patients presenting as persistent tumor. Early detection of those post-radiotherapy residual NPC is essential for early arrangement of salvage therapy. Detection methods include imaging, plasma Epstein-Barr virus DNA, endoscopy examinations and nasopharynx biopsy. NBI system has been well proven as a tool to detect early digestive tract cancer and head and neck cancer. However, there were only few studies targeting the detection of post-radiotherapy mucosal residual of NPC using NBI system Objective 1. To identify the vessel pattern of those confirmed NPC case using NBI system 2. To identify the endoscopy features of post-radiotherapy mucosal residual nasopharyngeal carcinoma using NBI system 3. To establish the positive predicted value, negative predicted value, sensitivity and specificity of using NBI system for detecting mucosal residual NPC Method: 1. All newly biopsy confirmed NPC patient will be assessed, their nasopharynx endoscopic image will be captured using both WL + NBI system 2. At post-radiotherapy 8th weeks, endoscopic examination will be arranged for patient using both WL + NBI system, biopsy will also be taken to detect mucosal residual NPC

Interventions

DEVICELaryngoscope with NBI system

All post-radiotherapy 8 weeks NPC patient will routinely undergo laryngoscope examination (WL system) and NP biopsy will be taken at the same time to determine if there is any residual NPC. In this study, laryngoscope with NBI system will be used. NBI system will be turn on during the post radiotherapy 8 week laryngoscope examination in additional to routine WL system

Sponsors

Pamela Youde Nethersole Eastern Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* all new NPC patient

Exclusion criteria

* History of radiotherapy to head and neck region * Poor premorbid status/ non-communicable patients * \<18 years old * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Positive Nasopharynx Biopsy Results Detected by NBI System in Those Post-radiotherapy 8th Week NPC PatientPost-radiotherapy 8th week4 grading of NBI vessel patterns can be identified in those post-radiotherapy 8 weeks NPC patients. Grade A: normal vessel size and length, regular pattern Grade B: normal vessel size, short, regular spiderweb like pattern Grade C: irregular vessel size and length, distorted and irregular pattern Grade D: thickened vessel size, elongated, distorted, and earthworm pattern

Secondary

MeasureTime frameDescription
The Sensitivity, Specificity, Positive Predicted Valve and Negative Predicted Valve of Detecting Mucosal Residual NPC Using NBI Suspicious/ Non Suspicous PatternPost-radiotherapy eight weeksNon suspicious pattern = grade A + grade B Suspicious pattern = grade C + D The sensitivity, specificity, positive predicted valve and negative predicted valve of detecting mucosal residual NPC using NBI suspicious/ non suspicous pattern can be thus calculated.
Assocication of Residual NPC With NBI Non Suspicious Pattern Group and NBI Suspicious Pattern GroupPost-radiotherapy eight weeksNon suspicious pattern = grade A + grade B Suspicious pattern = grade C + D The sensitivity, specificity, positive predicted valve and negative predicted valve of detecting mucosal residual NPC using NBI suspicious/ non suspicous pattern can be thus calculated.

Countries

Hong Kong

Participant flow

Participants by arm

ArmCount
Post Radiotherapy 8 Weeks NPC Patient
All post-radiotherapy 8 weeks NPC patient will routinely undergo laryngoscope examination (WL system) and NP biopsy will be taken at the same time to determine if there is any residual NPC. In this study, laryngoscope with NBI system will be used. NBI system will be turn on during the post radiotherapy 8 week laryngoscope examination in additional to routine WL system Laryngoscope with NBI system: All post-radiotherapy 8 weeks NPC patient will routinely undergo laryngoscope examination (WL system) and NP biopsy will be taken at the same time to determine if there is any residual NPC. In this study, laryngoscope with NBI system will be used. NBI system will be turn on during the post radiotherapy 8 week laryngoscope examination in additional to routine WL system
55
Total55

Baseline characteristics

CharacteristicPost Radiotherapy 8 Weeks NPC Patient
Age, Customized
< 18 years old
0 Participants
Age, Customized
>= 18 years old
55 Participants
NPC patients40 Participants
Race and Ethnicity Not Collected— Participants
Region of Enrollment
Hong Kong
55 participants
Sex: Female, Male
Female
8 Participants
Sex: Female, Male
Male
47 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 40
other
Total, other adverse events
0 / 40
serious
Total, serious adverse events
0 / 40

Outcome results

Primary

Positive Nasopharynx Biopsy Results Detected by NBI System in Those Post-radiotherapy 8th Week NPC Patient

4 grading of NBI vessel patterns can be identified in those post-radiotherapy 8 weeks NPC patients. Grade A: normal vessel size and length, regular pattern Grade B: normal vessel size, short, regular spiderweb like pattern Grade C: irregular vessel size and length, distorted and irregular pattern Grade D: thickened vessel size, elongated, distorted, and earthworm pattern

Time frame: Post-radiotherapy 8th week

ArmMeasureGroupValue (NUMBER)
Post Radiotherapy 8 Weeks NPC PatientPositive Nasopharynx Biopsy Results Detected by NBI System in Those Post-radiotherapy 8th Week NPC PatientGrade A, no residual NPC14 participants
Post Radiotherapy 8 Weeks NPC PatientPositive Nasopharynx Biopsy Results Detected by NBI System in Those Post-radiotherapy 8th Week NPC PatientGrade A, positive residual NPC1 participants
Post Radiotherapy 8 Weeks NPC PatientPositive Nasopharynx Biopsy Results Detected by NBI System in Those Post-radiotherapy 8th Week NPC PatientGrade B, no residual NPC20 participants
Post Radiotherapy 8 Weeks NPC PatientPositive Nasopharynx Biopsy Results Detected by NBI System in Those Post-radiotherapy 8th Week NPC PatientGrade B, positive residual NPC1 participants
Post Radiotherapy 8 Weeks NPC PatientPositive Nasopharynx Biopsy Results Detected by NBI System in Those Post-radiotherapy 8th Week NPC PatientGrade C, no residual NPC1 participants
Post Radiotherapy 8 Weeks NPC PatientPositive Nasopharynx Biopsy Results Detected by NBI System in Those Post-radiotherapy 8th Week NPC PatientGrade C, positive residual NPC1 participants
Post Radiotherapy 8 Weeks NPC PatientPositive Nasopharynx Biopsy Results Detected by NBI System in Those Post-radiotherapy 8th Week NPC PatientGrade D, no residual NPC1 participants
Post Radiotherapy 8 Weeks NPC PatientPositive Nasopharynx Biopsy Results Detected by NBI System in Those Post-radiotherapy 8th Week NPC PatientGrade D, positive residual NPC1 participants
Secondary

Assocication of Residual NPC With NBI Non Suspicious Pattern Group and NBI Suspicious Pattern Group

Non suspicious pattern = grade A + grade B Suspicious pattern = grade C + D The sensitivity, specificity, positive predicted valve and negative predicted valve of detecting mucosal residual NPC using NBI suspicious/ non suspicous pattern can be thus calculated.

Time frame: Post-radiotherapy eight weeks

Population: NBI non suspicious pattern = 36 NBI suspcious pattern = 4 Total = 40

ArmMeasureGroupCategoryValue (COUNT_OF_PARTICIPANTS)
Post Radiotherapy 8 Weeks NPC PatientAssocication of Residual NPC With NBI Non Suspicious Pattern Group and NBI Suspicious Pattern GroupNBI non suspicious patternwithout residual disease34 Participants
Post Radiotherapy 8 Weeks NPC PatientAssocication of Residual NPC With NBI Non Suspicious Pattern Group and NBI Suspicious Pattern GroupNBI non suspicious patternwith residual disease2 Participants
Post Radiotherapy 8 Weeks NPC PatientAssocication of Residual NPC With NBI Non Suspicious Pattern Group and NBI Suspicious Pattern GroupNBI suspicious patternwithout residual disease2 Participants
Post Radiotherapy 8 Weeks NPC PatientAssocication of Residual NPC With NBI Non Suspicious Pattern Group and NBI Suspicious Pattern GroupNBI suspicious patternwith residual disease2 Participants
Comparison: 2x2 table of: Row: 1. NBI suspicious pattern 2. NBI non-suspicious pattern Category: 1. with residual disease 2. without residual diseasep-value: 0.004Chi-squared
Secondary

The Sensitivity, Specificity, Positive Predicted Valve and Negative Predicted Valve of Detecting Mucosal Residual NPC Using NBI Suspicious/ Non Suspicous Pattern

Non suspicious pattern = grade A + grade B Suspicious pattern = grade C + D The sensitivity, specificity, positive predicted valve and negative predicted valve of detecting mucosal residual NPC using NBI suspicious/ non suspicous pattern can be thus calculated.

Time frame: Post-radiotherapy eight weeks

Population: NBI non suspicious pattern = 36 NBI suspcious pattern = 4 Total = 40

ArmMeasureGroupValue (NUMBER)
Post Radiotherapy 8 Weeks NPC PatientThe Sensitivity, Specificity, Positive Predicted Valve and Negative Predicted Valve of Detecting Mucosal Residual NPC Using NBI Suspicious/ Non Suspicous PatternSensitivity50 Percentage of participants
Post Radiotherapy 8 Weeks NPC PatientThe Sensitivity, Specificity, Positive Predicted Valve and Negative Predicted Valve of Detecting Mucosal Residual NPC Using NBI Suspicious/ Non Suspicous PatternPositive Predicted Valve50 Percentage of participants
Post Radiotherapy 8 Weeks NPC PatientThe Sensitivity, Specificity, Positive Predicted Valve and Negative Predicted Valve of Detecting Mucosal Residual NPC Using NBI Suspicious/ Non Suspicous PatternSpecificity94 Percentage of participants
Post Radiotherapy 8 Weeks NPC PatientThe Sensitivity, Specificity, Positive Predicted Valve and Negative Predicted Valve of Detecting Mucosal Residual NPC Using NBI Suspicious/ Non Suspicous PatternNegative Predicted Valve94 Percentage of participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026